FTY720 (Fingolimod)Hydrochloride
Selleck Chemicals
SKU:S5002-100MG
Couldn't load pickup availability

FTY720 (Fingolimod)Hydrochloride is an antagonist of S1P Receptors used in studies of GPCR Signaling. It is especially relevant in immunology and inflammation models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.
By blocking S1P Receptors, FTY720 (Fingolimod)Hydrochloride can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In immunology and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving S1P Receptors
- Pathway perturbation studies connected to GPCR Signaling
- Receptor-blockade and ligand-competition studies
- GPCR pharmacology, ligand-binding, and signaling assays
Overall, FTY720 (Fingolimod)Hydrochloride is appropriate when a defined chemical perturbant is needed to connect S1P Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- S1P Receptors
- Target Class:
- GPCR
- Pathways:
- GPCR Signaling
- Research Area:
- Immunology • Inflammation
- CAS No.:
- 162359-56-0
- Molecular Weight:
- 343.9
- Formula:
- C₁₉H₃₃NO₂·HCl
- SMILES:
- CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.